Corvus Pharmaceuticals, Inc. (CRVS) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.53 | +48.0% |
| 2024 | $-1.02 | -82.1% |
| 2023 | $-0.56 | +37.1% |
| 2022 | $-0.89 | +13.6% |
| 2021 | $-1.03 | -415.0% |
| 2020 | $-0.20 | +87.4% |
| 2019 | $-1.59 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.53 | +48.0% |
| 2024 | $-1.02 | -82.1% |
| 2023 | $-0.56 | +37.1% |
| 2022 | $-0.89 | +13.6% |
| 2021 | $-1.03 | -415.0% |
| 2020 | $-0.20 | +87.4% |
| 2019 | $-1.59 | — |